ライフサイエンスコーパス: hematocrit

1 latelet adhesion varies greatly with the RBC hematocrit.

2 elation between the actual and the predicted hematocrit.

3 , averting a potentially detrimental fall in hematocrit.

4 mia with an increase in RBC, hemoglobin, and hematocrit.

5 gination at 10%, 20%, and 30% red blood cell hematocrit.

6 ion increases EPO expression and the resting hematocrit.

7 easurements of blood and myocardium, and the hematocrit.

8 limited because it causes a systemic rise in hematocrit.

9 ficant odds ratio of 1.123 for pre-operative hematocrit.

10 ed due to a hemodilution-induced decrease in hematocrit.

11 vessels less than 12-14 mum depending on the hematocrit.

12 ntake and positive effects on hemoglobin and hematocrit.

13 exposed animals, accompanied by elevation of hematocrit.

14 levated EPO expression in bone and increased hematocrit.

15 or scrambled peptide treatment did not alter hematocrit.

16 pirate in relation to the patient's baseline hematocrit.

17 and matrix interference that increases with hematocrit.

18 tein metabolism products, blood pressure and hematocrit.

19 ded body weight, white blood cell count, and hematocrit.

20 x (ABRI=number of blood units/(final-initial hematocrit+0.01)), with a cutoff value of 0.75.

21 8 compared with -0.13 +/- 1.0; P = 0.01) and hematocrit (1.04 +/- 2.2 compared with -0.15 +/- 2.4; P

22 >=13.0 x 103/muL (2.54 [1.42-4.54]), higher hematocrit (1.83 [1.21-2.77] per 5% increase) and serum

23 our device across the physiological range of hematocrits (20-50%) with an average recovered plasma vo

24 s with severe (hematocrit, < 21%), moderate (hematocrit, 21-30%), and mild (hematocrit, > 30%) anemia

25 tated Ringer's solution titrated to maintain hematocrit +/- 3% from baseline levels.

26 nthly ESA dose of 75,000 units or higher and hematocrit 33% or less for at least 3 consecutive months

27 t group) or less intensive treatment (target hematocrit, 45 to 50%) (high-hematocrit group).

28 ured mean bias below 2.9% compared to normal hematocrit (47%) demonstrates that there is no significa

29 17.5 +/- 1.2 g/dL and 19.2 +/- 3.0 g/dL; and Hematocrit: 56.7 +/- 2.4% and 61.4 +/- 7.5%.

30 R (DynEq-CMR), where ECV is quantified using hematocrit-adjusted myocardial and blood T1 values measu

31 ight/d) lowered hemoglobin concentration and hematocrit after 6 d compared with nonsupplemented/NaCl-

32 a and is negatively influenced by fever, not hematocrit, age or leukocyte counts.

33 d data set with a baseline/discharge pair of hematocrit, albumin, or total protein values were includ

34 and indicators of disease severity (current hematocrit, albumin, total protein, aspartate aminotrans

35 For normal hematocrit and a capillary diameter of 6.75 mum, the pre

36 se with severe malaria, after adjustment for hematocrit and age.

37 G6PD deficiency by analyzing vital signs and hematocrit and by asking screening questions about sympt

38 ure or SVRI in patients with severe malaria, hematocrit and CFH but not asymmetric dimethylarginine w

39 These may include low hematocrit and coagulation abnormalities.

40 apacity is shown to increase with increasing hematocrit and decrease with increasing capillary diamet

41 ; and context-dependent effects on increased hematocrit and decreased C-reactive protein.

42 ent response at baseline, large increases in hematocrit and decreases in erythropoietin dosing were o

43 ry cortex, whereas there are large capillary hematocrit and erythrocyte flux differences.

44 ular bifurcations resulting in reductions in hematocrit and flow rate in the daughter and mother vess

45 s no association between vital parameters or hematocrit and G6PD deficiency.

46 There was no difference in mean hematocrit and hemoglobin between the 2 groups.

47 cyte maturation markers, erythrocyte counts, hematocrit and hemoglobin concentration were similar in

48 nlike wild type mice that manifest decreased hematocrit and hemoglobin levels when fed a low-iron die

49 Although EPO treatment increased hematocrit and improved glucose tolerance in male and fe

50 21 inhibitor led to significant increases in hematocrit and led to an increase in SMAD7 expression in

51 tion, prostate volume, sebum production, and hematocrit and lipid levels did not differ between group

52 tion, prostate volume, sebum production, and hematocrit and lipid levels.

53 assess the association between preoperative hematocrit and mortality, and the Youden J Index was use

54 we investigate the relationship between RBC hematocrit and platelet adhesion activity.

55 Hematocrit and prostate-specific antigen levels increase

56 r lung oxygen diffusing capacity in terms of hematocrit and pulmonary capillary diameter.

57 sphorus; and faster rate of decline of serum hematocrit and serum bicarbonate.

58 usly quantifying blood flow (velocity, flux, hematocrit and shear rate) in extended networks at singl

59 blood viscosity from its major determinants hematocrit and the level of fibrinogen and C-reactive pr

60 ients were stratified by postoperative nadir hematocrit and the presence of postoperative MI.

61 pomorphic Kit allele (W41/41) corrects their hematocrits and deficiencies in erythroid progenitor num

62 (4 studies, n = 318; P < .001), hemoglobin, hematocrit, and albumin may predict colectomy.

63 x revascularization, heart failure, smoking, hematocrit, and baseline platelet count, patients with a

64 bidity, rheology data (immunoglobulin level, hematocrit, and blood viscosity), clinical examination r

65 al cell viability, only transiently elevated hematocrit, and did not affect the magnitude of cerebral

66 Schistocytosis, a decrease in hematocrit, and elevated serum lactate dehydrogenase lev

67 netics, external factors such as shear rate, hematocrit, and GPIb and GPIIbIIIa receptor densities ha

68 n patients with unexplained edema, increased hematocrit, and hypotension.

69 including elevated plasma creatinine, lower hematocrit, and increased intact parathyroid hormone but

70 tion included weight, bypass circuit volume, hematocrit, and intraoperative measured and desired FibT

71 ature, release of mast cell mediators and/or hematocrit, and lung weight as a measure of vascular per

72 fraction, 24-hour ambulatory blood pressure, hematocrit, and NT-proBNP (N-terminal pro b-type natriur

73 trajectories with regard to their leukocyte, hematocrit, and platelet counts over time.

74 e correlates with anti-RBC antibodies, lower hematocrit, and reduced IL-7 signaling.

75 development, changes in rectal temperature, hematocrit, antigen-specific serum IgE, MCPT-1, and inte

76 correlations between vascular resistance and hematocrit are observed in various vessels, also defying

77 , and SOCS2(-/-)/Apc(Min/+) mice and assayed hematocrit as an indirect marker of disease severity.

78 ing time in vessel trauma and red blood cell hematocrit as platelets move to a vessel wall.

79 betes, lower creatinine clearance, decreased hematocrit, aspirin therapy, and nonsteroidal anti-infla

80 mo of age; P < 0.001), higher hemoglobin and hematocrit at 12 mo of age, and a significantly greater

81 ersus 10%), higher platelet count, and lower hematocrit at admission in the control group.

82 EPO 2500 led to a significant increase of hematocrit at day 4.

83 s 12.7%, respectively; P = .18) or mean (SD) hematocrit at discharge (34.5% [6.3%] vs 33.4% [6.8%], r

84 sociated with ECV (sex beta -0.33, p = 0.03; hematocrit beta -0.48, p < 0.01, model R(2) = 0.54, p <

85 ardiac surgery and had a nadir postoperative hematocrit between 20% and 30%.

86 demographics, hospital course (e.g., lowest hematocrit, blood loss), severity of illness (e.g., Sequ

87 neuroprotective function without effects on hematocrit, but this protein has a short half-life in vi

88 enous iron in hemodialysis patients within 4 hematocrit categories.

89 e-spot extraction method is less affected by hematocrit-caused errors, but it requires calibration of

90 Although we confirmed that low pre-operative hematocrit contributes to increased transfusions, we did

91 The primary end point was both hematocrit control through week 32 and at least a 35% re

92 Hematocrit control was achieved in 60% of patients recei

93 n J Index was used to determine the specific hematocrit cutoff point to define anemia in the neonatal

94 tive mortality for every percentage point of hematocrit decrease from the normal range.

95 lood urea nitrogen level, albumin level, and hematocrit) did not increase the risk of postoperative c

96 lambda (i.e., [Formula: see text]) can bias hematocrit distribution in tumor vascular networks and d

97 s in higher concentrations of hemoglobin and hematocrit during the neonatal period, and increased ser

98 is hampered by several issues, of which the hematocrit effect on DBS-based quantitation remains undo

99 A trajectory modeling, based on hematocrit evolution pattern, allowed identification of

100 precursor cells, the mice developed elevated hematocrit, expanded erythroid precursors, and suppresse

101 Hematocrit experiments show that Hct can influence the a

102 he relative decrease in platelet activity as hematocrit falls shows a similar profile for simulation

103 emoglobin to 18.6%, accompanied by increased hematocrit from 23% to 34% and reticulocyte reduction fr

104 developed a method to derive the approximate hematocrit from a nonvolumetrically applied DBS based on

105 ng both LC-MS/MS and gravimetric methods, on hematocrits from 26 to 62%.

106 metals with erythropoietic responses and/or hematocrit generated mixed results.

107 was recorded in 5 of 182 patients in the low-hematocrit group (2.7%) and 18 of 183 patients in the hi

108 up (2.7%) and 18 of 183 patients in the high-hematocrit group (9.8%) (hazard ratio in the high-hemato

109 it group, as compared with 10.9% in the high-hematocrit group (hazard ratio, 2.69; 95% CI, 1.19 to 6.

110 ive treatment (target hematocrit, <45%) (low-hematocrit group) or less intensive treatment (target he

111 eatment (target hematocrit, 45 to 50%) (high-hematocrit group).

112 ocrit group (9.8%) (hazard ratio in the high-hematocrit group, 3.91; 95% confidence interval [CI], 1.

113 osis occurred in 4.4% of patients in the low-hematocrit group, as compared with 10.9% in the high-hem

114 2, and 2 patients, respectively, in the low-hematocrit group, as compared with 2, 1, and 5 patients,

115 1, and 5 patients, respectively, in the high-hematocrit group.

116 ze clot formation in advanced liver disease: hematocrit >=25%, platelet count >50,000, and fibrinogen

117 %), moderate (hematocrit, 21-30%), and mild (hematocrit, > 30%) anemia in restrictive transfusion pro

118 At 6 months, hematocrit had increased more in the altitude group (5.1

119 effect of RBC membrane permeability (P(m)), hematocrit (Hct) and NO-Hb reaction rate constants on NO

120 the use of conventional DBS suffers from the hematocrit (hct) effect when analyzing a subpunch.

121 option resistance due to factors such as the hematocrit (Hct) effects and the established preference

122 Hematocrit (Hct) is one of the most critical issues asso

123 s, it is associated with several issues, the hematocrit (Hct) issue being the most widely discussed c

124 p < 0.001), neutrophil counts (P <0.001) and hematocrit (HCT) levels (P = 0.045).

125 In addition, the impact of blood hematocrit (Hct) on accurate quantification of the studi

126 tion by first measuring and then calculating hematocrit (Hct) values of whole blood samples with nomi

127 sting of two exercise training phases at two hematocrit (Hct) values: 30% (anemic) and 42% (physiolog

128 ffect to evaluate the spot volume effect and hematocrit (Hct) variation effect on target metabolites.

129 28 [lead SNP rs1050828; P < 1E - 13 for Hgb, hematocrit (Hct), MCV, RBC count and red cell distributi

130 (RBC) count, hemoglobin concentration (HGB), hematocrit (HCT), mean corpuscular hemoglobin (MCH), MCH

131 Hematocrit (HCT)-based assay bias (composed of area and

132 overcoming microsample collection issues and hematocrit (HCT)-related bias would facilitate more wide

133 blood folate (WBF), serum folate (SFOL), and hematocrit (Hct).

134 A (rs1800961, MAF = 2.4%, p < 3 x 10(-8) for hematocrit [HCT] and HGB).

135 Blood count, hematocrit, hemoglobin concentration and mean erythrocyt

136 ning disc to estimate the parameters such as hematocrit, hemoglobin, red blood cell (RBC), white bloo

137 resulted in diarrhea, hypothermia, increased hematocrit, high OVA-specific serum IgE, and MCPT-1 leve

138 n, suggested by similar body weight, BP, and hematocrit; however, plasma renin concentrations were mo

139 creases the concentrations of hemoglobin and hematocrit, improves mean systemic blood pressure, urine

140 crit in healthy mice, we measured effects of hematocrit in 2 in vivo clot formation models.

141 body weight, blood pressure, creatinine, or hematocrit in either group.

142 Using an experimental model of elevated hematocrit in healthy mice, we measured effects of hemat

143 e IIA ligand trap, increasing hemoglobin and hematocrit in pharmacologic models, in healthy volunteer

144 nd impeded the microvascular decrease of the hematocrit in the saline and pentastarch group.

145 as achieved for a sample of whole blood (30% hematocrit) in 10 min.

146 The blood hematocrit increased 10% at 2weeks, with no further chan

147 lagen at arterial shear rates, elevating the hematocrit increased the rate of platelet deposition and

148 In vitro, increasing the hematocrit increased thrombin generation in the absence

149 h included marked increase in hemoglobin and hematocrit, increased red blood cells, leukocytosis, thr

150 Mean hemoglobin and hematocrit increases after 90 d were greater for interve

151 imulations of whole blood predicted elevated hematocrit increases the frequency and duration of inter

152 Hematocrit independence and volumetric sampling performa

153 LC-MS/MS measurements confirm low CV and hematocrit independence of the sampling system and exhib

154 %) demonstrates that there is no significant hematocrit-induced bias.

155 rowth from 6 to 12 mo of age; 2) hemoglobin, hematocrit, iron [serum ferritin (SF)], and zinc status

156 ocoagulant properties in vitro, and elevated hematocrit is associated with reduced bleeding and incre

157 still unclear which parameter (hemoglobin or hematocrit) is the most reliable for demonstrating incre

158 y 27% of transfusions were associated with a hematocrit less than 21%.

159 ortality rates were highest in patients with hematocrit less than 30% (mortality, 2.1%) and lowest fo

160 on was found in the subgroup with the lowest hematocrit level (26 [interquartile range, 24-28]) (haza

161 18.7 g/dL; normal range, 13.6-17.2 g/dL) and hematocrit level (50.8%; normal range, 39%-49%).

162 ion thresholds, described as a hemoglobin or hematocrit level below which RBCs were transfused.

163 antly higher in neonates with a preoperative hematocrit level less than 40%; being 7.5% (95% CI, 1%-1

164 of 93 g/L (normal range, 130-170 g/L), and a hematocrit level of 0.27 (normal range, 0.4-0.5).

165 A preoperative hematocrit level of less than 40% was the optimal cutoff

166 Anemia defined as hematocrit level of less than 40%.

167 el, 7.9 g/dL (normal range, 13.5-18.0 g/dL); hematocrit level, 23.2% (0.23) (normal range, 40.0%-54.0

168 tigations, such as hemogram, glucose levels, hematocrit level, arterial pH, methanol levels, potassiu

169 Hematocrit level, thyroid stimulating hormone level, aut

170 V was calculated with input of the patient's hematocrit level.

171 raction (ECV) was derived accounting for the hematocrit level.

172 er major determinants of blood viscosity are hematocrit, level of inflammatory proteins and temperatu

173 ial operative blood loss or low preoperative hematocrit levels (<24%).

174 ous input volumes (40-80 muL), and different hematocrit levels (39-45%).

175 ell as hemoglobin concentration (P = 0.002), hematocrit levels (P = 9.5 x 10(-7)) and WBC count (P =

176 0%) vs 1.4% (95% CI, 0%-4%) for preoperative hematocrit levels 40%, or greater.

177 e also quantified the influence of different hematocrit levels and assessed the correlation of simult

178 day imprecision of quality controls at three hematocrit levels and at the lower and upper limit of qu

179 , and survival in AKI models without raising hematocrit levels and BP as substantially as EPO.

180 KI on CKD animals, with smaller increases in hematocrit levels and similarly improved survival.

181 In more recent years, patients had higher hematocrit levels before upper GI bleeding episodes and

182 oss (odds ratio: 0.35, 95% CI: 0.22-0.56 for hematocrit levels between 30%-35.9% and 0.78, 95% CI: 0.

183 Maintenance of normal hematocrit levels in Phd(2/3)hKO mice was accomplished b

184 Adiponectin and hematocrit levels increased more and fasting glucose, ur

185 isk reductions in patients with preoperative hematocrit levels of <24% (odds ratio: 0.60, 95% CI: 0.4

186 en 30%-35.9% and 0.78, 95% CI: 0.62-0.97 for hematocrit levels of 36% or greater).

187 me variations of less than 2% were seen with hematocrit levels ranging from 20% to 71%.

188 In Phd(1/2/3)hKO mice, hematocrit levels reached 82.4%, accompanied by severe v

189 exogenous erythropoietin but achieve higher hematocrit levels than those living at a lower altitude.

190 re model, Phd(2/3)hKO mice maintained normal hematocrit levels throughout the 8-week time course, whe

191 SVRI and hematocrit levels were lower and plasma CFH and asymmetr

192 e levels, reductions in leukocyte counts and hematocrit levels, and a higher incidence of non-basal-c

193 RBCs) travel into side branches at different hematocrit levels, and it is even possible that all RBCs

194 d to be largely independent of vessel angle, hematocrit levels, and measurement signal-to-noise ratio

195 maging, and across flow speed, vessel angle, hematocrit levels, and signal-to-noise ratio.

196 yed increased malaria parasitemia, decreased hematocrit levels, and suppressed malaria-specific antib

197 e overall mortality rate was lower at higher hematocrit levels, elevated mortality risk was associate

198 iated with decreased mortality risk at lower hematocrit levels, in which mortality rates are the high

199 efined as an increase in both hemoglobin and hematocrit levels, then further dichotomized into early

200 Hematocrit levels, vascular organization, and liver lipi

201 raits, we analyzed hemoglobin concentration, hematocrit levels, white blood cell (WBC) counts and pla

202 l, with smaller increases in systolic BP and hematocrit levels.

203 ficantly reduces splenomegaly and normalizes hematocrit levels.

204 iphase flows that is effective even for high hematocrit levels.

205 l and platelet counts but low hemoglobin and hematocrit levels.

206 n substantially increased erythropoietin and hematocrit levels.

207 ex (OR, 2.48; 95% CI, 1.20-5.13), and normal hematocrit (low vs. normal, OR, 0.26; 95% CI, 0.12-0.59)

208 ess (OR, 1.03; 95% CI, 1.01-1.04) and normal hematocrit (low vs. normal, OR, 0.31; 95% CI, 0.15-0.66)

209 ge (OR, 0.65; 95% CI, 0.47-0.90), lower mean hematocrit (low vs. normal, OR, 2.81; 95% CI, 1.06-7.49)

210 ium <130 mmol/L (OR, 1.8; 95% CI, 1.02-3.1), hematocrit <30% (OR, 2.0; 95% CI, 1.3-3.2), pleural effu

211 The primary and secondary outcomes were HUS (hematocrit <30% with smear evidence of hemolysis, platel

212 to assess the impact of preoperative anemia (hematocrit <39%) on postoperative 30-day mortality and a

213 azard ratio [HR]: 1.31), lower pre-operative hematocrit (</=31%) (HR: 1.31), ischemic etiology (HR: 1

214 time of first anemia (hemoglobin<10 gm/dL or hematocrit<30%) or first leukopenia (white blood cell [W

215 RBC transfusion among patients with severe (hematocrit, < 21%), moderate (hematocrit, 21-30%), and m

216 eive either more intensive treatment (target hematocrit, <45%) (low-hematocrit group) or less intensi

217 Maintaining a normal hematocrit may reduce arterial thrombosis risk in humans

218 difference, 2.0 [95% CI, 1.3-2.7] g/dL) and hematocrit (mean difference, 4.5% [95% CI, 1.5%-7.4%]) w

219 elet volume were significantly higher, while hematocrit, mean cell volume, and platelet counts were s

220 ardium pre- and post-gadolinium contrast and hematocrit measurement.

221 In addition, we found that neither hematocrit nor platelet count was significantly associat

222 nducible factor-1alpha activation (increased hematocrit), not exacerbated further by chronic hypoxia.

223 ciated with an increased risk for mortality (hematocrit of 20% to <24%: 7.3%; 24% to <27%: 3.7%; and

224 ociated with lower mortality, for those with hematocrit of 20% to 24% (odds ratio, 0.28; 95% CI, 0.13

225 For a tube hematocrit of 25% and a spherical protrusion with a diam

226 ignificantly higher mortality for those with hematocrit of 27% to 30% (odds ratio, 3.21; 95% CI, 1.85

227 60, 95% CI: 0.41-0.87), and in patients with hematocrit of 30% or greater when there is substantial (

228 (mortality, 2.1%) and lowest for those with hematocrit of 36% or higher (mortality, 0.7%).

229 structive method which allows to predict the hematocrit of a DBS based on its hemoglobin content, mea

230 ith polycythemia vera call for maintaining a hematocrit of less than 45%, but this therapeutic strate

231 herical particles, and tested the effects of hematocrit on particle local accessibility to flow area

232 Interestingly, the effects of hematocrit on specific circulation area was opposite for

233 association analyses of hematological trait, hematocrit, on 521 Korean family samples.

234 of a DBS suffices to derive its approximate hematocrit, one of the most important variables in DBS a

235 ular degenerative pathology without altering hematocrit or exacerbating neovascularization.

236 providing iron (thus further increasing the hematocrit) or reducing erythropoiesis-dependent iron co

237 splay these same differences in parasitemia, hematocrit, or antibody responses between the two groups

238 concentration, red cell distribution width, hematocrit, or hemoglobin.

239 associated with changes in gill morphology, hematocrit, or relative ventricular mass.

240 (P < .001); larger CRAE was related to lower hematocrit (P = .002).

241 covery (P = 0.002), decreasing elevations in hematocrit (P = 0.02), and increasing serum ferritin (P

242 le control-fed pigs had significantly higher hematocrit (p = 0.027), indicating continuing dehydratio

243 with atrial fibrillation (p = 0.066), lower hematocrit (p = 0.084), and more comorbidities according

244 0.001), peripheral resistance (P=0.014), and hematocrit (P<0.001).

245 , -5.8 to -0.6mmHg, P=0.02) and elevation of hematocrit (P=0.0003).

246 sheep, HRP reduced heart rate (P<0.001) and hematocrit (P=0.019) compared with time-matched control

247 significantly reduced the red blood cell and hematocrit parameters but increased the platelet counts

248 s to increased hemoglobin concentrations and hematocrit percentages and to a lower anemia prevalence

249 ars in raising hemoglobin concentrations and hematocrit percentages in anemic (hemoglobin concentrati

250 om baseline in hemoglobin concentrations and hematocrit percentages.

251 e, other aspects of vital organ support (eg, hematocrit, pH strategy), or cardiac anatomy.

252 re particles travel 1 cm downstream and that hematocrit plays a role in the degree of margination.

253 puncture included mortality, vascular leak, hematocrit, quantification of a panel of serum cytokines

254 ith less than 5% volume variation across the hematocrit range of 20-70% with low tip-to-tip variabili

255 Compared with controls, mice with elevated hematocrit (RBC(HIGH)) formed thrombi at a faster rate a

256 disrupted for HIF-2alpha demonstrated lower hematocrit, RBCs, and Hb compared with wild-type mice.

257 erior to standard therapy in controlling the hematocrit, reducing the spleen volume, and improving sy

258 in G6PD female heterozygotes, 2 of whom had hematocrit reductions to <23% requiring blood transfusio

259 Hematocrit reductions were clinically insignificant exce

260 However, hematocrit-related bias in combination with subpunch ana

261 ieving ELN response (complete or partial) or hematocrit response did not result in better survival or

262 ver the length scale of O(1 cm), with higher hematocrit showing faster margination.

263 ive abnormalities in RBCs, including altered hematocrit, sickle cell disease, thalassemia, hemolytic

264 tures of MF, including leukocytosis, reduced hematocrit, splenomegaly, and increased bone marrow reti

265 f thrombosis in PV is secured by phlebotomy (hematocrit target <45%) and in both PV and ET by low-

266 h and major thrombosis than did those with a hematocrit target of 45 to 50%.

267 atients with polycythemia vera, those with a hematocrit target of less than 45% had a significantly l

268 d phagocytose human erythrocytes causing the hematocrit to fall to 2.5% of the original value.

269 Reducing hematocrit to normal levels in tubular Vegfa-deficient m

270 s established for viscosity as a function of hematocrits to predict a rise and fall in viscosity duri

271 volume DBS samples irrespective of the blood hematocrit, to measure caffeine concentration in normal

272 CD, because they can easily be measured in a hematocrit tube.

273 assess because humans and mice with elevated hematocrit typically have coexisting pathologies.

274 ow in physiologic-sized tubes at physiologic hematocrit under controlled oxygenation conditions, whil

275 not meet the defined elevated hemoglobin or hematocrit value (>18.5 g/dL and 60% in men and >16.5 g/

276 ior to establishment of HUS and (2) a higher hematocrit value at presentation.

277 A hematocrit value greater than 23% as a measure of hydrat

278 h values in the Hif-p4h-2(gt/gt) mice and in hematocrit value in the Hif-p4h-3(-/-) mice than in the

279 culated based on the percentage reduction in hematocrit value of the aspirate in relation to the pati

280 (0-30 days old) with a recorded preoperative hematocrit value were included.

281 not meet the WHO criterion for an increased hematocrit value.

282 These forces increase significantly as hematocrit values approach 25% and decrease significantl

283 4497 administration increased hemoglobin and hematocrit values similarly in the P4h-tm(-/-) and wild-

284 ce nevertheless had increased hemoglobin and hematocrit values without any FG-4497 administration, al

285 Median hematocrit was 0.41 L/L (0.36-0.44 L/L) at admission and

286 mL) vs 19 mL (IQR, 0-46 mL); and weekly mean hematocrit was 3 percentage points higher with liberal t

287 postoperative blood transfusion, lower nadir hematocrit was associated with an increased risk for mor

288 A decrease in hematocrit was seen at a late interval (34-59 wk after t

289 pace perfusion (laser Doppler flowmetry) and hematocrit were analyzed.

290 , model R(2) = 0.29, p < 0.01) while sex and hematocrit were associated with ECV (sex beta -0.33, p =

291 Mean oxygen saturation, heart rate and hematocrit were not significantly different in G6PD defi

292 months, congenital heart disease, and lower hematocrit were risk factors for RF.

293 Body mass index, serum lipid levels, and hematocrit were strong phenotypic correlates of interind

294 Pretransfusion and final hematocrits were similar (P > 0.68).

295 ardial infarction, congestive heart failure, hematocrit, white blood cell count, mean corpuscular vol

296 an increase in red blood cells, hemoglobin, hematocrit, white blood cells, platelets, and splenomega

297 sting with the blood cell traits hemoglobin, hematocrit, white blood count, and platelet count.

298 ar events is reduced by sustained control of hematocrit with phlebotomies (low-risk patients) and/or

299 ocytes (MNLs) from diluted human blood (1-2% hematocrit) with high efficiency (>80%).

300 .2% and 1.2%, respectively, in patients with hematocrit within the normal range (P < 0.0001).